Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of ANAVEX LIFE SCIENCES CORP.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001314052.
Disclosed value leader
BlackRock, Inc.
Comparable rows
1/50
Latest evidence
30 Jun 2026
- Public ticker
- AVXL on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001314052
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ANAVEX LIFE SCIENCES CORP. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
1/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 5%
49 rows are not safely comparable across share classes.
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5%.
1 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 1
VANGUARD CAPITAL MANAGEMENT LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5%
Reported 13D/G
· 30 Jun 2026
|
$11,658,648
4,663,459 shares
|
$0 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$20,864,076
8,055,628 shares
|
— | 30 Jun 2026 |
| Christopher U. Missling |
3/4/5
President and CEO, Director
|
—
mixed-class rows
|
$14,467,380
1,635,165 shares
mixed-class rows
|
— | 06 Jan 2026 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
—
denominator unverified
|
$7,890,533
3,046,538 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$6,236,854
2,407,473 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$4,979,974
1,922,770 shares
|
— | 30 Jun 2026 |
| FEDERATED HERMES, INC. |
13F
Company
|
—
denominator unverified
|
$2,775,985
1,071,809 shares
|
— | 30 Jun 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$2,494,204
963,014 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 07 Nov 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to ANAVEX LIFE SCIENCES CORP.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Christopher U. Missling
Net 12M change
$0
Latest report
03 Nov 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher U. Missling | President and CEO, Director | $14,467,380 | Mixed | 06 Jan 2026 | ||
| Steffen Thomas | Director | $338,295 | Mixed | 05 Jun 2025 | ||
| Peter D.o. Donhauser | Director | $18,200 | Filing P/S | 03 Nov 2026 | ||
| Elliot Favus | Director | Mixed | 21 May 2021 | |||
| Sandra Boenisch | PFO & Treasurer | Mixed | 24 Sep 2026 | |||
| Claus Vander Velden | Director | Mixed | 03 Nov 2026 | |||
| Jiong Ma | Director | Mixed | 31 Mar 2025 | |||
| Athanasios Skarpelos | Director | Mixed | 31 Mar 2025 | |||
| Terrie Kellmeyer | President and CEO, Director | Mixed | 03 Nov 2026 | |||
| Gautam Patel | Director | Mixed | 24 Sep 2026 | |||
| Adrian Senderowicz | Director | Mixed | 24 Sep 2026 | |||
| Axel Paeger | Director | Mixed | 03 Nov 2026 |
Recent insider transactions for ANAVEX LIFE SCIENCES CORP.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Claus Vander Velden | AVXL | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 03 Nov 2026 | Direct | |||
| Peter D.o. Donhauser | AVXL | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 03 Nov 2026 | Direct | |||
| Terrie Kellmeyer | AVXL | Stock Option (Right to Buy) | Award | 200,000 | 200,000 | 03 Nov 2026 | Direct | |||
| Axel Paeger | AVXL | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 03 Nov 2026 | Direct | |||
| Sandra Boenisch | AVXL | Stock Option (Right to Buy) | Award | 45,000 | 25,000 | 24 Sep 2026 | Direct | |||
| Christopher U. Missling | AVXL | Stock Option (Right to Buy) | Award | 125,000 | 125,000 | 06 Jan 2026 | Direct | |||
| Sandra Boenisch | AVXL | Stock Option (Right to Buy) | Award | 12,500 | 12,500 | 06 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.